Scientific advisers to the Centers for Disease Control and Prevention on Thursday recommended a booster dose of the Pfizer-BioNTech vaccine for children ages 5 to 11.
Dr. Rochelle Walensky, the agency’s director, is expected to sign off quickly on the committee’s recommendation. Children in this age group who received their last dose at least five months earlier will then be eligible to receive booster doses immediately.
Recent Comments